A study was performed in order to elucidate the metabolic change of
35S-furosemide (
35S-FM) in control (C), renal failure (RF) and bilaterally nephrectomized rats (Nx). The suppressing effects of probenecid on
35S recovery and FM metabolites in urine and bile were also studied. Serum
35S-FM concentration in RF was higher than that in C, and T1/2 was 28 min in C and 34 min in RF.
35S recovery in urine within 2 hr following
35S-FM administration was 57% in C and 32% in RF, whereas
35S recovery in bile was 20% in C and 25% in RF. Fifty three percent of
35S was excreted into bile in Nx. Thus,
35S excretion into bile increased in RF and Nx. The FM metabolites, 4-Chloro-5-sulfamoyl anthranilic acid (CSA), Rf 0.76, and another metabolite (P-3), RI 0.50 were separated by thin layer chromatography and infrared spectrophotometry. FM and its metabolites were discovered in urine, bile and serum in C and RF. With respect to FM metabolism in C, the unmetabolized fraction of FM in urine was 68%, whereas that of FM in bile was only 10%. The fraction of unmetabolized FM increased in RF. FM metabolites disappeared from urine and decreased in bile following administration of probenecid. It is concluded that there is compensatory mechanism in biliary FM excretion in RF. Two substances are identified as FM metabolites which have no significant diuretic activity. Probenecid inhibits the excretion of FM and its metabolites.
View full abstract